Home › Compare › PARNF vs BTI

PARNF vs BTI: Dividend Comparison 2026

PARNF yields 2500.00% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PARNF wins by $80609755877.33M in total portfolio value
10 years
PARNF
PARNF
● Live price
2500.00%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80609755877.37M
Annual income
$74,729,580,081,858,750.00
Full PARNF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — PARNF vs BTI

📍 PARNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPARNFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PARNF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PARNF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PARNF
Annual income on $10K today (after 15% tax)
$212,500.00/yr
After 10yr DRIP, annual income (after tax)
$63,520,143,069,579,940.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, PARNF beats the other by $63,520,143,069,577,570.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PARNF + BTI for your $10,000?

PARNF: 50%BTI: 50%
100% BTI50/50100% PARNF
Portfolio after 10yr
$40304877938.70M
Annual income
$37,364,790,040,930,770.00/yr
Blended yield
92.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

PARNF
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PARNF buys
0
BTI buys
0
No recent congressional trades found for PARNF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPARNFBTI
Forward yield2500.00% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$80609755877.37M ✓$37.7K
Annual income after 10y$74,729,580,081,858,750.00 ✓$2,786.64
Total dividends collected$80198875900.38M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PARNF vs BTI ($10,000, DRIP)

YearPARNF PortfolioPARNF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$260,700$250,000.00$11,299$598.92+$249.4K → PARNF
2$6,370,070$6,091,121.50$12,794$703.91+$6.36M → PARNF
3$145,912,632$139,096,656.81$14,518$829.07+$145.90M → PARNF
4$3,133,830,814$2,977,704,297.75$16,513$978.64+$3133.81M → PARNF
5$63,122,812,060$59,769,613,088.96$18,827$1,157.84+$63122.79M → PARNF
6$1,192,683,724,131$1,125,142,315,226.76$21,518$1,373.12+$1192683.70M → PARNF
7$21,144,559,711,004$19,868,388,126,183.19$24,657$1,632.46+$21144559.69M → PARNF
8$351,818,906,448,043$329,194,227,557,269.44$28,329$1,945.74+$351818906.42M → PARNF
9$5,495,491,397,671,320$5,119,045,167,771,913.00$32,637$2,325.33+$5495491397.64M → PARNF
10$80,609,755,877,367,070$74,729,580,081,858,750.00$37,708$2,786.64+$80609755877.33M → PARNF

PARNF vs BTI: Complete Analysis 2026

PARNF — Stock

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Full PARNF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this PARNF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PARNF vs SCHDPARNF vs JEPIPARNF vs OPARNF vs KOPARNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.